The company concluded a year of significant growth in 2025, marked by record module sales and successful expansion of its domestic manufacturing footprint. Despite achieving an all-time high in module volume and meeting the upper end of its net sales guidance, a cautious outlook for 2026 has introduced a period of market volatility.
Financial and Operational Performance in 2025 The 2025 fiscal year was highlighted by record module sales of 17.5 gigawatts, representing a 24% increase year-over-year. Full-year net sales reached $5.2 billion, supported by the commissioning of a new factory in Louisiana. For the fourth quarter specifically, the company reported revenue of $1.68 billion. While this exceeded revenue expectations, earnings per share for the quarter came in at $4.84, missing consensus estimates.
The company maintained a strong liquidity position, ending the year with $2.4 billion in net cash. This financial stability was significantly bolstered by the successful monetization of Section 45X tax credits, with $1.4 billion recognized during the year. These credits continue to be a vital component of the company's profitability and cash flow strategy.
Strategic Technology Roadmap Management is actively advancing a dual-pillar technology strategy focused on the CURE semiconductor platform and next-generation perovskite thin-film modules. The CURE technology is designed to offer higher energy yields than conventional crystalline silicon alternatives. A phased rollout of this technology is scheduled to begin in Ohio, with subsequent integration across other manufacturing facilities.
In the realm of advanced research, the company achieved milestones in its perovskite program. It reached full in-line processing capabilities at its development line and entered into a pivotal licensing agreement to secure fundamental intellectual property. These efforts are aimed at establishing a path toward high-volume, low-cost manufacturing of thin-film technologies that could transform the solar market by 2027 and beyond.
Challenges and Outlook for 2026 Despite the successes of 2025, the company issued 2026 net sales guidance between $4.9 billion and $5.2 billion, which fell significantly below market expectations. This conservative forecast triggered a sharp decline in share price as investors reacted to projected stagnant growth.
Several headwinds are contributing to this outlook:

• Policy and Trade Uncertainty: The industry is navigating a complex regulatory environment characterized by potential tariff changes and permitting delays. The net impact of tariffs is expected to range between $125 million and $135 million in 2026.
• Manufacturing Realignment: While U.S. production remains fully allocated, international facilities in Southeast Asia are operating at low utilization rates (approximately 20%) due to constrained demand and the prevailing trade environment. Management views this underutilization as an "option value" to maintain flexibility for future market shifts.
• Onshoring Initiatives: To mitigate tariff risks and optimize domestic content, the company is establishing new finishing capacity in South Carolina. This facility will allow for the final processing of modules initiated at international sites to be completed in the U.S.

Market Position and Future Prospects The company enters 2026 with a substantial contracted backlog of 50.1 gigawatts valued at $15 billion. Management remains focused on "contract certainty" and disciplined customer selection to navigate global volatility. While the 2026 guidance suggests a transitional year with increased costs from factory ramps and underutilization, the long-term strategy emphasizes reshoring production to the United States and leveraging proprietary thin-film technology to maintain a competitive advantage over crystalline silicon manufacturers.
In international markets, the company has pivoted significantly toward India, where its facility is running at full capacity to serve robust domestic demand. This localized production provides a hedge against international trade barriers and benefits from structurally lower manufacturing costs.


Become a supporter of this podcast: https://www.spreaker.com/podcast/the-money-lab--6886555/support.